Adial Pharmaceuticals Files 2024 Annual Report
Ticker: ADIL · Form: 10-K · Filed: Mar 4, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 10-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Adial Pharma filed its 2024 10-K. All systems go for the year ahead.
AI Summary
Adial Pharmaceuticals, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware, is focused on pharmaceutical preparations. Its principal executive offices are located in Glen Allen, Virginia. The filing covers its operations and financial status for the year.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Adial Pharmaceuticals' performance, financial health, and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Adial Pharmaceuticals is subject to significant regulatory, clinical trial, and market risks inherent in drug development and commercialization.
Key Players & Entities
- ADIAL PHARMACEUTICALS, INC. (company) — Registrant
- 2024 (date) — Fiscal year end
- Delaware (location) — State of Incorporation
- Glen Allen, Virginia (location) — Principal business address
- 001-38323 (other) — Commission file number
FAQ
What is the primary business of Adial Pharmaceuticals, Inc.?
Adial Pharmaceuticals, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code [2834].
When did Adial Pharmaceuticals, Inc. file its annual report?
The 10-K filing was made on March 4, 2025, for the fiscal year ended December 31, 2024.
Where is Adial Pharmaceuticals, Inc. headquartered?
The company's principal business address is located at 4870 Sadler Road, Suite 300, Glen Allen, Virginia 23060.
What is the state of incorporation for Adial Pharmaceuticals, Inc.?
Adial Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SEC file number for Adial Pharmaceuticals, Inc.?
The commission file number for Adial Pharmaceuticals, Inc. is 001-38323.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 4, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).